Swee Lay Thein

Active 1985–2024

Also published as
Swee-Lay Thein
95
Papers
18,359
Citations
71
h-index
94
i10-index

Citations

Citations per year for Swee Lay Thein1985: 14 citations1986: 31 citations1987: 57 citations1988: 63 citations1989: 94 citations1990: 106 citations1991: 90 citations1992: 86 citations1993: 62 citations1994: 83 citations1995: 44 citations1996: 43 citations1997: 54 citations1998: 64 citations1999: 28 citations2000: 29 citations2001: 31 citations2002: 39 citations2003: 40 citations2004: 39 citations2005: 27 citations2006: 31 citations2007: 53 citations2008: 69 citations2009: 96 citations2010: 109 citations2011: 126 citations2012: 76 citations2013: 89 citations2014: 79 citations2015: 82 citations2016: 74 citations2017: 102 citations2018: 89 citations2019: 246 citations2020: 312 citations2021: 323 citations2022: 267 citations2023: 210 citations2024: 305 citations2025: 112 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,375 citing papers, 28.1% of this breakdownUnited Kingdom: 542 citing papers, 11.1% of this breakdownChina: 297 citing papers, 6.1% of this breakdownFrance: 219 citing papers, 4.5% of this breakdownGermany: 210 citing papers, 4.3% of this breakdownItaly: 210 citing papers, 4.3% of this breakdownCanada: 177 citing papers, 3.6% of this breakdownNetherlands: 162 citing papers, 3.3% of this breakdownJapan: 109 citing papers, 2.2% of this breakdownIndia: 102 citing papers, 2.1% of this breakdownAustralia: 97 citing papers, 2% of this breakdownSwitzerland: 74 citing papers, 1.5% of this breakdown
0%28.1%Other 26.9%

Fields

  • Medicine44.9%
  • Biochemistry, Genetics and Molecular Biology40.3%
  • Agricultural and Biological Sciences4.9%
  • Immunology and Microbiology2.5%
  • Environmental Science2.3%
  • Neuroscience1.4%
  • Other3.7%

Topics

  • Hemoglobinopathies and Related Disorders10%
  • Iron Metabolism and Disorders4.9%
  • Molecular Biology Techniques and Applications3.9%
  • Blood groups and transfusion3.6%
  • Erythrocyte Function and Pathophysiology2.5%
  • Prenatal Screening and Diagnostics2.2%
  • Other72.9%

Coauthors

All papers

Open in search
  1. Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR

    Authors: , , , - BMC Molecular Biology 2006 cited by 1,746

  2. Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2021 cited by 122

  3. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support

    Authors: , , , , , , , , , , , , , , - Blood Advances 2020 cited by 463

  4. Recent Advances in the Treatment of Sickle Cell Disease

    Authors: , - Frontiers in Physiology 2020 cited by 196

  5. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15

    Authors: , , , , , , , , , , , , , , - Nature Genetics 2007 cited by 530

  6. A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease

    Authors: , , , , , , , , , , , , , , , , , , , - Blood 2022 cited by 72

  7. Hypervariable ‘minisatellite’ regions in human DNA

    Authors: , , - Nature 1985 cited by 3,778

  8. Sickle Cell Anemia and Its Phenotypes

    Authors: , - Annual Review of Genomics and Human Genetics 2018 cited by 142

  9. The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase

    Authors: , , , , , , , , , - Blood Advances 2018 cited by 100

  10. Anemia in the elderly: clinical implications and new therapeutic concepts

    Authors: , - Haematologica 2014 cited by 128

  11. Molecular basis of β thalassemia and potential therapeutic targets

    Authors: - Blood Cells Molecules and Diseases 2017 cited by 208

  12. MYB – A regulatory factor in hematopoiesis

    Authors: , , - Gene 2018 cited by 90

  13. Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania

    Authors: , , , , , , , , , , , , , - PLoS ONE 2014 cited by 110

  14. Cardiovascular complications of sickle cell disease

    Authors: , , - Trends in Cardiovascular Medicine 2020 cited by 72

  15. Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 59

  16. Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 29

  17. Individual-specific ‘fingerprints’ of human DNA

    Authors: , , - Nature 1985 cited by 2,175

  18. HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers

    Authors: , , , , , , , , , , , , - Journal of Clinical Investigation 2014 cited by 214

  19. Reversible binding of hemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte properties

    Authors: , , , , , , , , - Blood 2016 cited by 85

  20. Treating sickle cell anemia

    Authors: , , - Science 2020 cited by 81

  21. Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood Cells Molecules and Diseases 2022 cited by 36

  22. Dietary iron restriction improves markers of disease severity in murine sickle cell anemia

    Authors: , , , , , , , , , , - Blood 2020 cited by 22

  23. Control of fetal hemoglobin: new insights emerging from genomics and clinical implications

    Authors: , , , - Human Molecular Genetics 2009 cited by 253

  24. Survival in adults with sickle cell disease in a high-income setting

    Authors: , , , , , , - Blood 2016 cited by 227